Hussein Mahmoud Rezk Abd-Elwahed, Wood Gary Stewart
Department of Medicine (Dermatology), University of Wisconsin and William S. Middleton Memorial Veteran Hospital, Madison, WI 53705, USA.
J Mol Diagn. 2002 May;4(2):71-80. doi: 10.1016/S1525-1578(10)60684-8.
Melanocytic dysplastic nevi were first described in both patients and their relatives who had one or several cutaneous malignant melanomas. Most of these dysplastic lesions are biologically stable, but some of them have severe histological atypia and can progress further to melanomas. Although several studies have suggested the etiological importance of dysplastic nevi in the development of melanomas, comprehensive reviews of the molecular changes in these dysplastic lesions are still scarce. To remedy this issue, this article analyzes the available molecular information about dysplastic nevi and provides the current state of knowledge regarding the karyotypic abnormalities of the melanoma/dysplastic nevus trait and the involvement of allelic loss, tumor suppressor genes, mismatch repair proteins, microsatellite instability, oncogenes, extracellular matrix proteins, and growth factors in the genesis of these lesions. These studies suggest that although some of these lesions represent "genetic dead-ends," others represent intermediate lesional steps in the melanoma tumorigenesis pathway.
黑素细胞发育异常痣最初在患有一个或多个皮肤恶性黑色素瘤的患者及其亲属中被描述。这些发育异常性病变大多在生物学上是稳定的,但其中一些具有严重的组织学异型性,并且可能进一步发展为黑色素瘤。尽管多项研究表明发育异常痣在黑色素瘤发生过程中具有病因学重要性,但对这些发育异常性病变分子变化的全面综述仍然很少。为解决这一问题,本文分析了关于发育异常痣的现有分子信息,并提供了有关黑色素瘤/发育异常痣特征的核型异常以及等位基因缺失、肿瘤抑制基因、错配修复蛋白、微卫星不稳定性、癌基因、细胞外基质蛋白和生长因子在这些病变发生过程中的作用的当前知识状态。这些研究表明,尽管其中一些病变代表“遗传终点”,但其他病变代表黑色素瘤肿瘤发生途径中的中间病变步骤。